Identity
- Trade Name
- Phoenix Surgical Wound Matrix Fenestrated FDA UDI
- Generic Name
- Synthetic nanofiber barrier dressing FDA UDI
- Model / Reference
- FG-0054 FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00852513007409 FDA UDI
- FDA Product Code
- FRO FDA UDIQSZ FDA UDI
- GMDN Term
- Synthetic nanofiber barrier dressing FDA UDI
Classification
- Device Class
- U FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Synthetic nanofiber barrier dressing
Phoenix Surgical Wound Matrix Fenestrated by Nanofiber Solutions Llc — Class U — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Synthetic nanofiber barrier dressing.
- Phoenix Wound Matrix — NANOFIBER SOLUTIONS LLC · U
- Phoenix Wound Matrix — NANOFIBER SOLUTIONS LLC · U
- Anthem Wound Matrix Fenestrated — NANOFIBER SOLUTIONS LLC · U
- Phoenix Wound Matrix Fenestrated — NANOFIBER SOLUTIONS LLC · U
- Phoenix Wound Matrix Fenestrated — NANOFIBER SOLUTIONS LLC · U
- Phoenix Wound Matrix Fenestrated — NANOFIBER SOLUTIONS LLC · U
- Phoenix Wound Matrix — NANOFIBER SOLUTIONS LLC · U
- ElectroFiber 3D Matrix — NANOFIBER SOLUTIONS LLC · U
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class U | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Nanofiber Solutions Llc
Sources (1)
- FDA UDI d6946fd4-3b00-42a4-ac8e-2d0ab7ae37fc 32 fields · synced May 30, 2026